Anemia treatment and the radiation oncologist: Optimizing patient outcomes

ONCOLOGY

Volumn 15, Issue 11, 2001, Pages 1486-1491

  Shasha, Daniel ^b   Harrison, Louis B ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ANEMIA; BLOOD; HUMAN; NEOPLASM; ONCOLOGY; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY; REVIEW;

ANEMIA; ERYTHROPOIETIN; HEMOGLOBINS; HUMAN; NEOPLASMS; PROGNOSIS; QUALITY OF LIFE; RADIATION ONCOLOGY; RADIOTHERAPY; SUPPORT, NON-U.S. GOV'T;

EID: 0035514836     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Demetri GD, Kris M, Wade J, et al, for the Procrit Study Group: Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study. J Clin Oncol 16:3412-3425, 1998.
2. Glaspy J, Bukowski R, Steinberg D, et al, for the Procrit Study Group: Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol 15:1218-1234, 1997.
3. Vogelzang NJ, Breitbart W, Cella D, et al: Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. Semin Hematol 34(suppl 2):4-12, 1997.
4. Curt GA, Breitbart W, Cella DF, et al: Impact of cancer-related fatigue on the lives of patients (abstract 2214). Proc Am Soc Clin Oncol 18:573a, 1999.
5. Portenoy RK, Itri LM: Cancer-related fatigue: Guidelines for evaluation and management. Oncologist 4:1-10, 1999.
6. Cella D: The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(suppl 2): 13-19, 1997.
7. Cella D: Factors influencing quality of life in cancer patients: Anemia and fatigue. Semin Oncol 25(suppl 7):43-46, 1998.
8. Yellen SB, Cella DF, Webster K, et al: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13:63-74, 1997.
9. Greenberg DB, Sawicka J, Eisenthal S, et al: Fatigue syndrome due to localized radiation. J Pain Symptom Manage 7:38-45, 1992.
10. Haylock PJ, Hart LK: Fatigue in patients receiving localized radiation. Cancer Nurs 2:461-467, 1979.
11. King KB, Nail LM, Kreamer K, et al: Patients' descriptions of the experience of receiving radiation therapy. Oncol Nurs Forum 12:55-61, 1985.
12. Kobashi-Schoot JAM, Hanewald GJFP, Van Dam FSAM, et al: Assessment of malaise in cancer patients treated with radiotherapy. Cancer Nurs 8:306-313, 1985.
13. Lavey RS, Dempsey WH: Erythropoietin increases hemoglobin in cancer patients during radiation therapy. Int J Radiat Oncol Biol Phys 27:1147-1152, 1993.
14. Pedersen D, Søgaard H, Overgaard J, et al: Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone. Acta Oncologica 34:787-795, 1995.
15. Groopman JE, Itri LM: Chemotherapy-induced anemia in adults: Incidence and treatment. J Natl Cancer Inst 91:1616-1633, 1999.
16. Harrison LB, Shasha S, Shiaova L, et al: Prevalence of anemia in cancer patients undergoing radiotherapy (abstract 1849). Proc Am Soc Clin Oncol 19:471a, 2000.
17. Hong J-H, Tsai C-S, Chang JT, et al: The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy. Int J Radiat Oncol Biol Phys 41:823-830, 1998.
18. Kagei K, Shirato H, Nishioka T, et al: High-dose-rate intracavitary irradiation using linear source arrangement for stage II and III squamous cell carcinoma of the uterine cervix. Radiother Oncol 47:207-213, 1998.
19. Logsdon MD, Eifel PJ: FIGO IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 43:763-775, 1999.
20. Mundt AJ, Connell PP, Campbell T, et al: Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol 71:151-158, 1998
21. Takeshi K, Katsuyuki K, Yoshiaki T, et al: Definitive radiotherapy combined with highdose rate brachytherapy for stage III carcinoma of the uterine cervix: Retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters. Int J Radiat Oncol Biol Phys 41:319-327, 1998.
22. Dubray B, Mosseri V, Brunin F, et al: Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: A prospective study. Radiology 201:553-558, 1996.
23. Fein DA, Lee WR, Hanlon AL, et al: Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 13:2077-2083, 1995.
24. Lee WR, Berkey B, Marcial V, et al: Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 42:1069-1075, 1998.
25. Stadler P, Becker A, Feldmann HJ, et al: Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 44:749-754, 1999.
26. Warde P, O'Sullivan B, Bristow RG, et al: T1/T2 glottic cancer managed by external-beam radiotherapy: The influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys 41:347-353, 1998.